2025-2031 Global Veterinary Vaccine Adjuvants Industry Research & Trends Analysis Report- YH Research

Home > Reports >Pharma & Healthcare > 2025-2031 Global Veterinary Vaccine Adjuvants Industry Research & Trends Analysis Report

2025-2031 Global Veterinary Vaccine Adjuvants Industry Research & Trends Analysis Report

Publication Date: 2025-12-01
Report Id: 2799025
Industry: Pharma & Healthcare
Report Page: 127
Chart: 125

PDF Download

Publication Date: 2025-12-01
Report Id: 2799025
Industry: Pharma & Healthcare
Report Page: 127
Chart: 125

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Veterinary Vaccine Adjuvants Definition
1.2 Global Veterinary Vaccine Adjuvants Market Size and Forecast
1.2.1 By Revenue, Global Veterinary Vaccine Adjuvants Market Size, 2020-2031
1.2.2 By Sales Volume, Global Veterinary Vaccine Adjuvants Market Size, 2020-2031
1.2.3 Global Veterinary Vaccine Adjuvants Price Trend, 2020-2031
1.3 China Veterinary Vaccine Adjuvants Market Size and Forecast
1.3.1 By Revenue, China Veterinary Vaccine Adjuvants Market Size, 2020-2031
1.3.2 By Sales Volume, China Veterinary Vaccine Adjuvants Market Size, 2020-2031
1.3.3 China Veterinary Vaccine Adjuvants Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Veterinary Vaccine Adjuvants Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Veterinary Vaccine Adjuvants Share in Global Market, 2020-2031
1.4.3 Veterinary Vaccine Adjuvants Market Size: China VS Global, 2020-2031
1.5 Veterinary Vaccine Adjuvants Market Dynamics
1.5.1 Veterinary Vaccine Adjuvants Market Drivers
1.5.2 Veterinary Vaccine Adjuvants Market Restraints
1.5.3 Veterinary Vaccine Adjuvants Industry Trends
1.5.4 Veterinary Vaccine Adjuvants Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Veterinary Vaccine Adjuvants Revenue by Company, 2020-2025
2.2 Global Veterinary Vaccine Adjuvants Sales Volume by Company, 2020-2025
2.3 Global Veterinary Vaccine Adjuvants Price by Company, 2020-2025
2.4 Global Veterinary Vaccine Adjuvants Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Veterinary Vaccine Adjuvants Concentration Ratio
2.6 Global Veterinary Vaccine Adjuvants Mergers & Acquisitions, Expansion Plans
2.7 Global Veterinary Vaccine Adjuvants Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Veterinary Vaccine Adjuvants Revenue by Company, 2020-2025
3.2 China Veterinary Vaccine Adjuvants Sales Volume by Company, 2020-2025
3.3 China Veterinary Vaccine Adjuvants Veterinary Vaccine Adjuvants Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Veterinary Vaccine Adjuvants Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Veterinary Vaccine Adjuvants Domestic VS Export
3.6 China Market, Veterinary Vaccine Adjuvants Import & Export
3.6.1 China Market, Veterinary Vaccine Adjuvants Import & Export, 2020-2031
3.6.2 China Veterinary Vaccine Adjuvants Import & Export Trends
3.6.3 Main Sources of China Veterinary Vaccine Adjuvants Import
3.6.4 Export Destination of China Veterinary Vaccine Adjuvants

4 Veterinary Vaccine Adjuvants Production by Region
4.1 Global Veterinary Vaccine Adjuvants Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Veterinary Vaccine Adjuvants Manufacturers
4.3 Global Major Manufacturers, Veterinary Vaccine Adjuvants Capacity Expansion and Future Plans
4.4 Global Veterinary Vaccine Adjuvants Capacity by Region
4.5 Global Veterinary Vaccine Adjuvants Production by Region
4.5.1 Global Veterinary Vaccine Adjuvants Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Veterinary Vaccine Adjuvants Production by Region, 2020-2025
4.5.3 Global Veterinary Vaccine Adjuvants Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Veterinary Vaccine Adjuvants Industry Chain
5.2 Veterinary Vaccine Adjuvants Upstream Analysis
5.2.1 Veterinary Vaccine Adjuvants Core Raw Materials
5.2.2 Main Manufacturers of Veterinary Vaccine Adjuvants Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Veterinary Vaccine Adjuvants Production Mode
5.6 Veterinary Vaccine Adjuvants Procurement Model
5.7 Veterinary Vaccine Adjuvants Industry Sales Model and Sales Channels
5.7.1 Veterinary Vaccine Adjuvants Sales Model
5.7.2 Veterinary Vaccine Adjuvants Typical Distributors

6 Sights by Type
6.1 Veterinary Vaccine Adjuvants Classification by Type
6.1.1 Emulsion Adjuvants
6.1.2 Mineral Adjuvants
6.1.3 Others
6.2 by Type, Global Veterinary Vaccine Adjuvants Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Veterinary Vaccine Adjuvants Revenue, 2020-2031
6.4 by Type, Global Veterinary Vaccine Adjuvants Sales Volume, 2020-2031
6.5 by Type, Global Veterinary Vaccine Adjuvants Price, 2020-2031

7 Sights by Functional Purpose
7.1 Veterinary Vaccine Adjuvants Classification by Functional Purpose
7.1.1 Immune Enhancement
7.1.2 Immune Modulation
7.1.3 Other
7.2 by Functional Purpose, Global Veterinary Vaccine Adjuvants Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Functional Purpose, Global Veterinary Vaccine Adjuvants Revenue, 2020-2031
7.4 by Functional Purpose, Global Veterinary Vaccine Adjuvants Sales Volume, 2020-2031
7.5 by Functional Purpose, Global Veterinary Vaccine Adjuvants Price, 2020-2031

8 Sights by Compatible Vaccine Type
8.1 Veterinary Vaccine Adjuvants Classification by Compatible Vaccine Type
8.1.1 Inactivated Vaccine
8.1.2 Live Attenuated Vaccine
8.1.3 Subunit Vaccine
8.1.4 Other
8.2 by Compatible Vaccine Type, Global Veterinary Vaccine Adjuvants Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by Compatible Vaccine Type, Global Veterinary Vaccine Adjuvants Revenue, 2020-2031
8.4 by Compatible Vaccine Type, Global Veterinary Vaccine Adjuvants Sales Volume, 2020-2031
8.5 by Compatible Vaccine Type, Global Veterinary Vaccine Adjuvants Price, 2020-2031

9 Sights by Application
9.1 Veterinary Vaccine Adjuvants Segment by Application
9.1.1 Livestock Vaccines
9.1.2 Companion Animals Vaccines
9.2 by Application, Global Veterinary Vaccine Adjuvants Market Size & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Veterinary Vaccine Adjuvants Revenue, 2020-2031
9.4 by Application, Global Veterinary Vaccine Adjuvants Sales Volume, 2020-2031
9.5 by Application, Global Veterinary Vaccine Adjuvants Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Veterinary Vaccine Adjuvants Market Size, 2020 VS 2024 VS 2031
10.2 By Region, Global Veterinary Vaccine Adjuvants Revenue, 2020-2031
10.3 By Region, Global Veterinary Vaccine Adjuvants Sales Volume, 2020-2031
10.4 North America
10.4.1 North America Veterinary Vaccine Adjuvants Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Veterinary Vaccine Adjuvants Market Size Market Share
10.5 Europe
10.5.1 Europe Veterinary Vaccine Adjuvants Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Veterinary Vaccine Adjuvants Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Veterinary Vaccine Adjuvants Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Veterinary Vaccine Adjuvants Market Size Market Share
10.7 South America
10.7.1 South AmericaVeterinary Vaccine Adjuvants Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Veterinary Vaccine Adjuvants Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Veterinary Vaccine Adjuvants Market Size & CAGR，2020 VS 2024 VS 2031
11.2 By Country, Global Veterinary Vaccine Adjuvants Revenue, 2020-2031
11.3 By Country, Global Veterinary Vaccine Adjuvants Sales Volume, 2020-2031
11.4 United States
11.4.1 United States Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.4.2 By Company, United States Veterinary Vaccine Adjuvants Sales Volume Market Share, 2024
11.4.3 by Type, United States Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.4.4 by Application, United States Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.5.2 By Company, Europe Veterinary Vaccine Adjuvants Sales Volume Market Share, 2024
11.5.3 by Type, Europe Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.5.4 by Application, Europe Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.6 China
11.6.1 China Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.6.2 By Company, China Veterinary Vaccine Adjuvants Sales Volume Market Share, 2024
11.6.3 by Type, China Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.6.4 by Application, China Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.7.2 By Company, Japan Veterinary Vaccine Adjuvants Market Share, 2024
11.7.3 by Type, Japan Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.7.4 by Application, Japan Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.8.2 By Company, South Korea Veterinary Vaccine Adjuvants Market Share, 2024
11.8.3 by Type, South Korea Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.8.4 by Application, South Korea Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.9.2 By Company, Southeast Asia Veterinary Vaccine Adjuvants Market Share, 2024
11.9.3 by Type, Southeast Asia Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.9.4 by Application, Southeast Asia Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.10 India
11.10.1 India Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.10.2 By Company, India Veterinary Vaccine Adjuvants Market Share, 2024
11.10.3 by Type, India Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.10.4 by Application, India Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Veterinary Vaccine Adjuvants Market Size, 2020-2031
11.11.2 By Company, Middle East & Africa Veterinary Vaccine Adjuvants Market Share, 2024
11.11.3 by Type, Middle East & Africa Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031
11.11.4 by Application, Middle East & Africa Veterinary Vaccine Adjuvants Market Size, Share, 2024 VS 2031

12 Manufacturers Profile
12.1 SEPPIC
12.1.1 SEPPIC Company Information, Head Office, Market Area, and Industry Position
12.1.2 SEPPIC Veterinary Vaccine Adjuvants Models, Specifications, and Application
12.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.1.4 SEPPIC Company Profile and Main Business
12.1.5 SEPPIC Recent Developments
12.2 SDA BIO
12.2.1 SDA BIO Company Information, Head Office, Market Area, and Industry Position
12.2.2 SDA BIO Veterinary Vaccine Adjuvants Models, Specifications, and Application
12.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.2.4 SDA BIO Company Profile and Main Business
12.2.5 SDA BIO Recent Developments
12.3 Croda
12.3.1 Croda Company Information, Head Office, Market Area, and Industry Position
12.3.2 Croda Veterinary Vaccine Adjuvants Models, Specifications, and Application
12.3.3 Croda Veterinary Vaccine Adjuvants Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Croda Company Profile and Main Business
12.3.5 Croda Recent Developments
12.4 SPI Pharma
12.4.1 SPI Pharma Company Information, Head Office, Market Area, and Industry Position
12.4.2 SPI Pharma Veterinary Vaccine Adjuvants Models, Specifications, and Application
12.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.4.4 SPI Pharma Company Profile and Main Business
12.4.5 SPI Pharma Recent Developments
12.5 Phibro Animal Health
12.5.1 Phibro Animal Health Company Information, Head Office, Market Area, and Industry Position
12.5.2 Phibro Animal Health Veterinary Vaccine Adjuvants Models, Specifications, and Application
12.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Phibro Animal Health Company Profile and Main Business
12.5.5 Phibro Animal Health Recent Developments
12.6 Vertellus
12.6.1 Vertellus Company Information, Head Office, Market Area, and Industry Position
12.6.2 Vertellus Veterinary Vaccine Adjuvants Models, Specifications, and Application
12.6.3 Vertellus Veterinary Vaccine Adjuvants Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Vertellus Company Profile and Main Business
12.6.5 Vertellus Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Veterinary Vaccine Adjuvants should grow from US$ 370 million in 2024 to US$ 579 million by 2031, with a CAGR of 6.5% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Veterinary Vaccine Adjuvants

According to YH Research, the global market for Veterinary Vaccine Adjuvants should grow from US$ 370 million in 2024 to US$ 579 million by 2031, with a CAGR of 6.5% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Veterinary vaccine adjuvants are auxiliary substances used together with antigens in animal vaccines (either concurrently or as a pre-treatment) to enhance or modulate the immune response of the host to these antigens. Compared with traditional vaccines relying solely on antigen content, adjuvants significantly improve immune protection for livestock, poultry, pets, and aquatic animals by prolonging antigen persistence in the body, enhancing antigen presentation, activating innate immune pathways, and stimulating lymphocyte proliferation and differentiation. These adjuvants are compatible with inactivated vaccines, recombinant vaccines, subunit vaccines and emerging vaccine platforms. In 2024, global Veterinary vaccine adjuvants production reached approximately 20 million L, with an average global market price of around US$ 17.4 per L.The average gross   profit margin of this product is 43%.

The veterinary vaccine adjuvants market is currently at a rapid growth stage, driven fundamentally by a significant rise in global demand for animal health, preventive vaccination, and animal‑derived food safety. First, expanding population and growing consumption of animal protein have led to larger scale livestock farming, raising the importance of disease prevention — in turn boosting demand for high‑performance vaccines and adjuvants. Second, the steady growth in companion animals (pets) — increasing pet ownership and stronger pet‑health awareness — drives demand for preventive vaccination and premium immune solutions, thereby raising demand for safe, high‑efficacy adjuvants. Third, advances in biotechnology, nanotechnology, lipid‑based delivery systems and novel adjuvant research enable newer vaccine platforms (e.g. recombinant, subunit) to achieve robust immune responses via adjuvants, opening huge opportunities for next‑generation adjuvants. Finally, growing attention by governments and public health authorities to animal epidemic control, zoonosis prevention, and food‑security regulation brings policy support and market validation to the industry. Altogether, these forces create a “golden window” of high growth, high investment and high return potential for veterinary vaccine adjuvants.

However, despite favorable prospects, the veterinary vaccine adjuvant industry faces substantial challenges and risks. First, stringent regulation and high safety/efficacy requirements — different animal species and vaccine types impose varied tolerances, thus novel adjuvants must undergo rigorous validation, which prolongs development cycles and raises R&D and registration costs. Second, traditional adjuvants (e.g. mineral‑based) have limitations in inducing strong T‑cell responses and long‑lasting immunity, which means their utility is diminishing when dealing with modern highly purified or novel vaccines; development of advanced adjuvants (lipid, nanoparticle, polysaccharide, saponin-based) requires significant investment, while raw materials may face supply, purity or stability issues. Third, in many developing regions, awareness and acceptance of advanced adjuvant‑based vaccines remain low; basic or traditional vaccines still dominate, limiting market penetration. Lastly, market concentration is increasing: a few established players with strong R&D, regulatory and scale advantages control major share, creating high entry barriers; this may inhibit smaller or innovative companies and slow down overall innovation adoption.

On the downstream side, demand patterns for veterinary vaccine adjuvants are evolving significantly. In livestock and poultry sectors, demand for high‑efficacy vaccines continues to rise, especially in intensive farming and large‑scale poultry operations, where adjuvants become essential for efficient herd immunity and reduced vaccination frequency. The companion animal segment (pets) remains a stable and fast‑growing market, as pet owners increasingly prioritize preventive healthcare and are willing to pay for higher safety and efficacy — driving demand for adjuvanted pet vaccines. Beyond traditional intramuscular injection vaccines, the industry is exploring mucosal (e.g. nasal, oral) or more convenient delivery routes. These routes require adjuvants with high safety, stability and good immunostimulatory profiles, thereby spurring demand for advanced adjuvant formulations. Overall, downstream demand is shifting from simple disease prevention toward comprehensive animal health management, production efficiency enhancement for livestock, and pet health maintenance — offering broad and diversified application scenarios for adjuvant manufacturers.

The upstream raw materials for veterinary vaccine adjuvants cover a range of traditional and advanced components, including mineral salts (e.g. aluminum salts), lipids/liposomes, polymeric or carbomer systems, nanoparticles, saponins, polysaccharides, and other biocompatible carrier materials. Conventional mineral‑based adjuvants remain prevalent due to low cost, mature manufacturing processes and historical regulatory acceptance, but their capacity to induce strong T‑cell mediated immunity or support long‑lasting protective responses is limited — creating a bottleneck for modern vaccine demands. Newer materials — lipid carriers, oil-in-water or water-in-oil emulsions, polymer/nanoparticle systems — enable precise antigen delivery, sustained release, and stronger immune activation, and are increasingly favored. Moreover, sustainable, plant‑derived or polysaccharide/saponin-based adjuvants (e.g. QS‑21) are gaining attention, especially for pet and poultry vaccines where safety and environmental impact matter. However, these advanced raw materials present challenges in supply chain stability, extraction/purification consistency, batch-to-batch repeatability, and compliance with regulatory standards. Ultimately, the diversity and technological maturity of upstream raw materials will determine whether a manufacturer can secure differentiation and leadership in the evolving adjuvant market.

This report aims to provide a comprehensive study of the global market for Veterinary Vaccine Adjuvants. 
Report Highlights:
(1) Global Veterinary Vaccine Adjuvants market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Veterinary Vaccine Adjuvants market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Veterinary Vaccine Adjuvants market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Veterinary Vaccine Adjuvants segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Veterinary Vaccine Adjuvants segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Veterinary Vaccine Adjuvants, capacity, production and trends.

(7) Veterinary Vaccine Adjuvants industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Emulsion Adjuvants
    Mineral Adjuvants
    Others

Market segment by Functional Purpose, covers
    Immune Enhancement
    Immune Modulation
    Other

Market segment by Compatible Vaccine Type, covers
    Inactivated Vaccine
    Live Attenuated Vaccine
    Subunit Vaccine
    Other

Market segment by Application, can be divided into
    Livestock Vaccines
    Companion Animals Vaccines

Market segment by players, this report covers
    SEPPIC
    SDA BIO
    Croda
    SPI Pharma
    Phibro Animal Health
    Vertellus